Determination of a reference value for NG, NG‐dimethyl‐L‐arginine in 500 subjects

F. Schulze,R. Maas,R. Freese,E. Schwedhelm,E. Silberhorn,R. Böger
DOI: https://doi.org/10.1111/j.1365-2362.2005.01561.x
2005-10-01
European Journal of Clinical Investigation
Abstract:Background  Asymmetric dimethylarginine (ADMA) acts as an endogenous inhibitor of NO‐synthase. In the last years ADMA has emerged as a cardiovascular risk factor. The aim of this study was to determine a reference value for ADMA.
What problem does this paper attempt to address?